Prospective Multicenter, Clinical Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
A Study of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients (HIV)
Sponsor: NIAID
Enrolling: Male and Female Patients
IRB Number: AAAS2561
U.S. Govt. ID: NCT03734393
Contact: Marcus Pereira, MD, MPH: 212-305-3839 /
Additional Study Information: The primary objective of this study is to determine if an HIV-infected donor liver (HIVD+) transplant is safe with regards to major transplant-related and HIV-related complications. This study will evaluate if receiving a liver transplant from an HIV-infected deceased liver donor is safe with regards to survival and major transplant-related and HIV-related complications compared to receiving a liver from an HIV-uninfected deceased liver donor (HIVD-). Those participants who have accepted a HIVD- organ will be randomized to be followed in the full study or followed in the nested observational group.
Marcus Pereira, MD, MPH
Do You Qualify?
Are you 18 years of age or older? Yes No
Are you HIV-positive? Yes No
Are you eligible for a liver transplant? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Marcus Pereira, MD, MPH